丙型肝炎病毒感染相关的肠道菌群失调
研究比较166例丙型肝炎病毒(HCV)感染者和23名健康人的粪便菌群,发现感染者细菌多样性降低,慢性肝炎和肝硬化患者粪便pH显著高于健康人及持续ALT正常者,提示草绿色链球菌过度生长可能参与高氨血症。
要点
- HCV感染与肠道菌群失调相关,即使轻度肝病阶段也已出现。
- 随疾病进展,脲酶基因增加,与慢性肝炎和肝硬化患者粪便pH升高一致。
- 草绿色链球菌过度生长可能解释慢性肝炎和肝硬化患者的高氨血症。
核心结论
- HCV感染与肠道菌群失调相关,即使在轻度肝病患者中也存在。
- 草绿色链球菌过度生长可解释慢性肝炎和肝硬化患者的高氨血症。
- 作者认为进一步研究有助于提出新的治疗策略,因肠道微生物组可被治疗性改变,可能减少慢性肝病并发症。
研究设计与样本
- 比较研究,分析166例慢性丙型肝炎(CHC)患者与23名健康个体的粪便样本,采用16S核糖体RNA基因测序分析肠道菌群。
- CHC患者分组:持续血清丙氨酸氨基转移酶正常且无肝硬化证据(PNALT,n=18)、慢性肝炎(CH,n=84)、肝硬化(LC,n=40)、肝硬化合并肝细胞癌(n=24)。
主要发现
- 与健康个体相比,HCV感染者细菌多样性较低,梭菌目减少,链球菌属和乳杆菌属增加。
- PNALT阶段已出现菌群失调,表现为拟杆菌属和肠杆菌科短暂增加。
- 预测宏基因组分析显示,CHC进展过程中脲酶基因增加,主要由草绿色链球菌编码。
- CH和LC患者粪便pH显著高于健康个体或PNALT阶段患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the effect of hepatitis C virus (HCV) infection on gut microbiota and the relationship between alteration of gut microbiota and chronic hepatitis C (CHC) progression. We performed a comparative study of gut microbiota composition between CHC patients and healthy individuals. METHODS: Fecal samples from 166 CHC patients were compared with those from 23 healthy individuals; the gut microbiota community was analyzed using 16S ribosomal RNA gene sequencing. CHC patients were diagnosed with persistently normal serum alanine aminotransferase without evidence of liver cirrhosis (LC) (PNALT, n = 18), chronic hepatitis (CH, n = 84), LC (n = 40), and hepatocellular carcinoma in LC (n = 24). RESULTS: Compared with healthy individuals, bacterial diversity was lower in persons with HCV infection, with a decrease in the order Clostridiales and an increase in Streptococcus and Lactobacillus. Microbiota dysbiosis already appeared in the PNALT stage with the transient increase in Bacteroides and Enterobacteriaceae. Predicted metagenomics of microbial communities showed an increase in the urease gene mainly encoded by viridans streptococci during CHC progression, consistent with a significantly higher fecal pH in CH and LC patients than in healthy individuals or those in the PNALT stage. CONCLUSIONS: HCV infection is associated with gut dysbiosis, even in patients with mild liver disease. Additionally, overgrowth of viridans streptococci can account for hyperammonemia in CH and LC. Further studies would help to propose a novel treatment strategy because the gut microbiome can be therapeutically altered, potentially reducing the complications of chronic liver disease.
引用
- Inoue T, Nakayama J, Moriya K, et al. Gut Dysbiosis Associated With Hepatitis C Virus Infection. Clin Infect Dis. 2018. PMID: 29718124. doi:10.1093/cid/ciy205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。